The 2024 Medical Laboratory Observer State of the Industry survey on Disease Management focused on diabetes (type 1 and type 2) and sexually transmitted infection testing. Alongside the quantitative results, we include commentary from BD, Hologic, Nova Biomedical, Revvity, and Roche Diagnostics on diabetes and STI sampling and testing trends and innovations. Download now to learn more.
This content is sponsored by:
